Delphistem is a BioTech company offering an innovative stem cell solution. With the goal of preventing and healing life threatening diseases, Delphistem collects urine samples, reprograms them into stem cells, and stores them for future medical use. With potential applications in regenerative medicine, pharmacology, and toxicology, this type of stem cell reprogramming has the potential to provide personalize healthcare, such as medication testing and organ replacements, using an individual's own stem cells.
